Amanta Healthcare Limited

Amanta Healthcare Limited

Amanta Healthcare Limited has informed the Exchange regarding 'Intimation - Regulation 36(1)(b) of the SEBI Listing Regulations'. The company has sent a letter to shareholders providing a web-link for accessing the Annual Report for the Financial Year 2025-26. The 31st Annual General Meeting (AGM) of Amanta Healthcare Limited is scheduled to be held on September 16, 2026, through Video Conferencing (VC) facility / Other Audio Visual Means (OAVM).

Amanta Healthcare Limited

Amanta Healthcare Limited has informed the Exchange about the dispatch of Annual Report of the 31st Annual General Meeting (AGM) and E-Voting Information through a newspaper publication.

Amanta Healthcare Limited

Amanta Healthcare Limited has informed the Exchange about Notice of Annual General Meeting to be held on 16th September, 2026

Amanta Healthcare Limited

Amanta Healthcare Limited has informed the Exchange about a copy of newspaper publication - advertisement addressed to shareholders for the Annual General Meeting.

Amanta Healthcare Limited

Amanta Healthcare Limited held a Q1 FY27 Earnings Conference Call, reporting revenue of INR69 crores, up 5% year-on-year, and maintaining a healthy EBITDA margin of approximately 22%. The company is expanding its manufacturing capabilities and product portfolio, with its SteriPort platform contributing 44% of revenue and expected to witness strong customer acceptance. The expansion of the SteriPort facility has been delayed due to operational issues, but the company remains confident in its growth prospects.

Amanta Healthcare Limited

Amanta Healthcare Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, detailing the utilization of the fund raised through its public issue. The report, issued by CRISIL Ratings Limited, indicates that the company has not deviated from the objects of the issue.

Amanta Healthcare Limited

Amanta Healthcare Limited has informed the Exchange about the publication of its financial results for the quarter ended June 30, 2026, in newspapers and on its website.

Amanta Healthcare Limited

Amanta Healthcare Limited has informed the Exchange about Newspaper Publication of Financial Results for Quarter ended June 30, 2026.

Amanta Healthcare Limited

Amanta Healthcare Limited has submitted the audio recording of its post-results conference call held on August 6, 2026, which can be accessed on the company's website.

Amanta Healthcare Limited

Amanta Healthcare Limited announces Q1FY27 results with stable margins and strategic capacity build-out continuing. Revenue grew 5.4% YoY, EBITDA margin moderated to 22% from 24%, and PAT declined 5.6% YoY due to higher finance costs.

Amanta Healthcare Limited

Amanta Healthcare Limited has informed the Exchange about Investor Presentation on Financial Results of the Company for the quarter ended June 30, 2026.

Amanta Healthcare Limited

Amanta Healthcare Limited has submitted a statement of deviation or variation in utilization of funds raised through its IPO for the quarter ended June 30, 2026, as per Regulation 32 of the SEBI Listing Regulations. The company confirms that there has been no deviation or variation in the use of proceeds of funds raised through Public Issue.

Amanta Healthcare Limited

Amanta Healthcare Limited has submitted its financial results for the quarter ended June 30, 2026, and has approved the appointment of a scrutinizer for its upcoming Annual General Meeting.

Amanta Healthcare Limited

Amanta Healthcare Limited has informed the Exchange about change in Senior Management Personnel of the Company, with the inclusion of Mr. Nilesh Punjabi as Senior Management Personnel (SMP) as Assistant Vice President (HR & Admin).

Amanta Healthcare Limited

Amanta Healthcare Limited has scheduled an analyst/investor conference call to discuss Q1 FY27 financial performance and business updates on August 6, 2026.

Amanta Healthcare Limited

Amanta Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018.

Amanta Healthcare Limited

Amanta Healthcare Limited has informed the Exchange about the outcome of its Investor/Analyst Meeting, where officials interacted with investors and analysts on July 9, 2026. The meeting was virtual, and no unpublished price sensitive information (UPSI) was discussed or shared.

Amanta Healthcare Limited

Amanta Healthcare Limited has informed the Exchange about the schedule of an investor/analyst meeting on July 9, 2026, with ValPro Capital.

Amanta Healthcare Limited

Amanta Healthcare Limited has submitted disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, regarding an off-market transfer of equity shares.

Amanta Healthcare Limited

Amanta Healthcare Limited has informed the Exchange about a copy of Newspaper Publication regarding a special window for transfer and dematerialization requests of physical shares.